• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

偶然分枝杆菌复合群中各微生物对抗结核及其他抗菌药物的敏感性。

Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents.

作者信息

Sanders W E, Hartwig E C, Schneider N J, Cacciatore R, Valdez H

出版信息

Antimicrob Agents Chemother. 1977 Aug;12(2):295-7. doi: 10.1128/AAC.12.2.295.

DOI:10.1128/AAC.12.2.295
PMID:900925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC429903/
Abstract

Of 21 antimicrobial agents tested in vitro, amikacin was the most predictably active against clinical isolates belonging to the Mycobacterium fortuitum complex; however, only 50% of strains studied were susceptible to clinically attainable concentrations of the drug.

摘要

在体外测试的21种抗菌药物中，阿米卡星对偶然分枝杆菌复合体的临床分离株活性最具可预测性；然而，仅50%的研究菌株对该药物临床可达到的浓度敏感。

相似文献

1
Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents.偶然分枝杆菌复合群中各微生物对抗结核及其他抗菌药物的敏感性。
Antimicrob Agents Chemother. 1977 Aug;12(2):295-7. doi: 10.1128/AAC.12.2.295.
2
In vitro drug susceptibility of Mycobacterium other than tubercle bacilli.
J Med Assoc Thai. 1990 Aug;73(8):438-42.
3
Antimicrobial susceptibility testing of Mycobacterium fortuitum complex.偶然分枝杆菌复合体的药敏试验
Antimicrob Agents Chemother. 1979 Jun;15(6):754-7. doi: 10.1128/AAC.15.6.754.
4
Antimicrobial Susceptibility Testing and Molecular Characterization of Mycobacterium fortuitum Isolates in China.中国偶然分枝杆菌分离株的药敏试验及分子特征分析
Biomed Environ Sci. 2017 May;30(5):376-379. doi: 10.3967/bes2017.049.
5
In vitro susceptibility of Mycobacterium fortuitum to non-antituberculous antibacterial agents.偶然分枝杆菌对非抗结核抗菌药物的体外敏感性
Ann Microbiol (Paris). 1983 Jan-Feb;134A(1):73-8. doi: 10.1016/0769-2609(83)90105-9.
6
[Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo].[在体外和体内实验中，庆大霉素与阿米卡星联合利福平、乙胺丁醇和异烟肼对选定分枝杆菌标准菌株的作用]
Pneumonol Pol. 1989 May;57(5):300-7.
7
Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.偶然分枝杆菌和龟分枝杆菌对抗菌剂敏感性的纸片扩散试验
Antimicrob Agents Chemother. 1979 Nov;16(5):611-4. doi: 10.1128/AAC.16.5.611.
8
Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.偶然分枝杆菌和龟分枝杆菌五个亚组的抗菌药敏性
Antimicrob Agents Chemother. 1985 Dec;28(6):807-11. doi: 10.1128/AAC.28.6.807.
9
In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands.荷兰 49 种 2275 株临床非结核分枝杆菌分离株的体外药物敏感性。
Int J Antimicrob Agents. 2010 Feb;35(2):169-73. doi: 10.1016/j.ijantimicag.2009.09.023. Epub 2009 Dec 16.
10
Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.左氧氟沙星对非结核分枝杆菌的活性谱及其与乙胺丁醇、利福平、罗红霉素、阿米卡星和氯法齐明联合对鸟分枝杆菌复合群的活性。
Antimicrob Agents Chemother. 1996 Nov;40(11):2483-7. doi: 10.1128/AAC.40.11.2483.

引用本文的文献

1
In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents.快速生长分枝杆菌对新型抗菌药物的体外敏感性
Antimicrob Agents Chemother. 1994 Jan;38(1):134-7. doi: 10.1128/AAC.38.1.134.
2
In vitro studies with Win 42122-2: comparison with gentamicin, netilmicin, and amikacin.Win 42122-2的体外研究：与庆大霉素、奈替米星和阿米卡星的比较。
Antimicrob Agents Chemother. 1981 Aug;20(2):247-51. doi: 10.1128/AAC.20.2.247.
3
In vitro susceptibility of Mycobacterium fortuitum to cefoxitin.偶然分枝杆菌对头孢西丁的体外敏感性
Antimicrob Agents Chemother. 1981 Jan;19(1):205-7. doi: 10.1128/AAC.19.1.205.
4
In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.偶然分枝杆菌对N-甲酰亚胺基硫霉素及几种头孢霉素的体外敏感性
Antimicrob Agents Chemother. 1982 Dec;22(6):1079-81. doi: 10.1128/AAC.22.6.1079.
5
Mycobacterial isolations in young adults with cystic fibrosis.患有囊性纤维化的年轻成年人中的分枝杆菌分离情况。
Thorax. 1984 May;39(5):369-75. doi: 10.1136/thx.39.5.369.
6
Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.偶然分枝杆菌和龟分枝杆菌五个亚组的抗菌药敏性
Antimicrob Agents Chemother. 1985 Dec;28(6):807-11. doi: 10.1128/AAC.28.6.807.
7
In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.偶然分枝杆菌和龟分枝杆菌对头孢美唑的体外敏感性
Antimicrob Agents Chemother. 1985 Feb;27(2):282-3. doi: 10.1128/AAC.27.2.282.
8
Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice.氧氟沙星联合干酪乳杆菌对小鼠偶然分枝杆菌感染的影响。 你提供的原文中“of ofloxacin”多了一个“of”，正确表述应该是“Effect of ofloxacin...” 。
Antimicrob Agents Chemother. 1990 Apr;34(4):632-6. doi: 10.1128/AAC.34.4.632.
9
Postoperative osteomyelitis due to Mycobacterium fortuitum. A case report.偶然分枝杆菌所致术后骨髓炎。病例报告。
Arch Orthop Trauma Surg. 1992;111(3):178-80. doi: 10.1007/BF00388095.
10
Prosthetic valve endocarditis due to Mycobacterium fortuitum.偶然分枝杆菌所致人工瓣膜心内膜炎
Can Med Assoc J. 1978 Jul 22;119(2):154-5.

本文引用的文献

1
M. fortuitum: its identification, incidence, and significance in Florida.龟分枝杆菌：其在佛罗里达州的鉴定、发病率及意义
Am Rev Respir Dis. 1962 Jan;85:84-91. doi: 10.1164/arrd.1962.85.1.84.
2
Drug-susceptibility testing in tuberculosis; a method using diluted bacterial suspensions for the indirect test.结核病药敏试验；一种使用稀释菌悬液进行间接试验的方法。
Am Rev Tuberc. 1958 Feb;77(2):350-5. doi: 10.1164/artpd.1958.77.2.350.
3
Mycobacterium fortuitum--a human pathogen.偶然分枝杆菌——一种人类病原体。
Ann Intern Med. 1970 Dec;73(6):971-7. doi: 10.7326/0003-4819-73-6-971.
4
Activity of gentamicin against mycobacteria in vitro and against Mycobacterium tuberculosis in mice.庆大霉素在体外对分枝杆菌以及在小鼠体内对结核分枝杆菌的活性。
J Infect Dis. 1971 Dec;124 Suppl:S33-6. doi: 10.1093/infdis/124.supplement_1.s33.
5
A study on pulmonary disease associated with mycobacteria other than Mycobacterium tuberculosis: identification and characterization of the mycobacteria. 18. A report of the Veterans Administration-Armed Forces Cooperative Study.一项关于除结核分枝杆菌外其他分枝杆菌所致肺部疾病的研究：分枝杆菌的鉴定与特征分析。18. 退伍军人管理局 - 武装部队合作研究报告。
Am Rev Respir Dis. 1967 Jun;95(6):954-71. doi: 10.1164/arrd.1967.95.6.954.
6
Mycobacteria in soil and their relation to disease-associated strains.
Am Rev Respir Dis. 1968 Jun;97(6):1032-7. doi: 10.1164/arrd.1968.97.6P1.1032.
7
Ten mycobacterial pathogens.十种分枝杆菌病原体。
Tubercle. 1974 Sep;55(3):235-40. doi: 10.1016/0041-3879(74)90051-8.
8
Differential identification of mycobacteria. VII. Key features for identification of clinically significant mycobacteria.分枝杆菌的鉴别诊断。VII. 临床重要分枝杆菌鉴定的关键特征。
Am Rev Respir Dis. 1973 Jan;107(1):9-21. doi: 10.1164/arrd.1973.107.1.9.
9
Atypical mycobacteria in a tuberculosis hospital.一家结核病医院中的非典型分枝杆菌
Can Med Assoc J. 1976 Apr 3;114(7):612-4.
10
The pathogenicity of Mycobacterium fortuitum and Mycobacterium chelonei in man: a report of seven cases.偶然分枝杆菌和龟分枝杆菌对人类的致病性：7例报告
Tubercle. 1976 Mar;57(1):49-57. doi: 10.1016/0041-3879(76)90017-9.